Search
 
 
 

WHO WE ARE

Staff, Contact us, About

 
NEWS
Vacant positions for IT specialists
We are looking for full-time employees:
Experienced IT architect to define the IT infrastructure for Personalised Medicine for Data Center East
Position info&application
Developers to implement the IT infrastructure for Personalised Medicine for Data Center East
Position info&application
Deadline for application 19 March.
Vacant position Biostatistician HIV/TB/HCV
We are looking for a full‐time biostatistician for projects at Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet.
Deadline for application is 28th February.
Learn more about the position here.
Immunologic colloquium on 27th February 2019
On February 27th 2019 PERSIMUNE invites you to the next immunologic colloquium at Rigshospitalet.
Come to listen to Dr Anne-Mette Lebech talk about Tick-borne diseases research and Dr Carsten U Niemann share updates on CLL research in PERSIMUNE. 
AGENDA Please confirm your attendance by sending an email to persimune.rigshospitalet@regionh.dk
Nye Retningslinjer for håndtering af influenza i Danmark
Influenza’en er ved at udvikle sig i DK: nye retningslinjer for sundhedsvæsnet håndtering er netop færdiggjort . Se mere her
 
Re-launch of EACS Online Course on Clinical Management of HIV

The course is a free and flexible online alternative for busy clinicians in need of in-depth training on the clinical management of HIV. Designed for clinicians from Eastern Europe and Central Asia - with Russian subtitles - but everyone can participate!

Read more about the course here and enroll here

There will be a moderated period from 19 November 2018 – 10 February 2019 where you can interact with the faculty

New PERSIMUNE publication
Cancer-chemotherapy induced febrile neutropenia: First report from PERSIMUNE on this topic by Nordvig et al, suggesting that the development of febrile neutropenia identifies a subgroup of those treated with persistent vulnerability to contract subsequent serious infections. Read more here

Aagaard et al has developed algorithms able to reliable patients at risk of febrile neutropenia – in press. Future research efforts to better understand the biological mechanisms explaining the vulnerability are required.
PhD defence Neval Ete Wareham
Neval Ete Wareham will be defending her ph.d. thesis on "Incidence and Risk of Solid Cancer and Lymphoproliferative Disease after Transplantation" 
5 November 2018 14:00 -17:00 at Rigshospitalet Auditorium 2, Opgang 44 Blegdamsvej 9, 2100 København
Program
Info
All are welcome!
PhD defence Isabelle Lodding
Isabelle Lodding will be defending her ph.d. thesis on "Dynamics of Cytomegalovirus Replication and Disease in Solid Organ and Hematopoietic Stem Cell Recipients" 20th September 14:00 -17:00 at Rigshospitalet Auditorium 2, Opgang 44 Blegdamsvej 9, 2100 København
Program
Info
All are welcome!
HIV training and mentoring programme

CHIP has launched the HIV training and mentoring programme for Ukrainian doctors in collaboration with WHO Regional Office in Ukraine. During this week the Ukrainian doctors will visit different hospitals in Copenhagen Region and other health institutions to meet the infectious diseases specialists who will share their knowledge and present on international standards for HIV treatment and care. 

Can hypothermia reduce organ dysfunction and mortality in patients with septic shock?
Read more about the results of the latest PERSIMUNE research which was published in Lancet Respiratory Medicine.
New publication: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study
Marco Gelpi and collegues from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study affiliated with PERSIMUNE recently reported data indicating that even well-treated and in particular older HIV-positive persons remains having a distrinct pro-atherogenic phenotype compared to age and gender matched sections of the general population. This observation renders supports for notions from other sections of research by CHIP and PERSIMUNE, that HIV status is an independent risk factor for cardiovascular disease.  Research focused on identifying mechanisms explaining the development of the phenotype and interventions to contract its likely adverse reactions is underway. 
Abstract
Wall of fame PERSIMUNE Data Warehouse
Acknowledgement of the huge work done in relation to the establishment of the PERSIMUNE Datawarehouse
See the Wall of Fame for the PERSIMUNE Data Warehouse





 
MISP - Talks: The new horizon in biomedicine
Join the MISP - Talks: The new horizon in biomedicine 
8 December 2017 16-19 
Jerne Auditorium in Mærsk Tower
The Panum Institute

Open to all, scientists and general public.
The MISP talks are a series of forward looking talks on precision
medicine and the emerging new science frontiers and technologies,
presented by leading international experts.

Please find full programme and register for the event here
EACS Guidelines 9.0
In relation to the recent EACS conference in Milan, Version 9.0 of the EACS Guidelines was launched. The massive work in reviewing and updating the EACS Guidelines is led by Prof Manuel Battegay with the support of Dr. Lene Ryom from CHIP.
The guidelines are an essential tool for clinicians assisting their work in the fast evolving field of HIV treatment. Version 9.0 of the Guidelines includes revisions to the sections on antiretroviral treatment, co-morbidities, opportunistic infections and Hepatitis C.

Read more about the latest updates and the work around the EACS Guidelines here
Find the latest version of the EACS Guidelines here

 
EACS 2017
16th European AIDS Conference 25-27 October 2017, Milan, Italy

CHIP is represented with 7 presentations at EACS 2017, 2 oral presentations and 5 poster presentations

Please find all presentations HERE
Available positions at CHIP
CHIP is looking to fill a position as Post Doc in biostatistics and is also hiring a student for our IT department. Read more about the positions HERE
ID WEEK 2017 - San Diego 4-8 October 2017
CHIP will be represented at IDWEEK 2017 with 8 presentations. 
1 oral presentation and 7 poster presentations.

See all presentations here
Launch of the Joint Action - INTEGRATE
19t September the Joint Action on integrating prevention, testing and link to care strategies across HIV, viral hepatitis, TB and STIs in Europe - INTEGRATE - will be launched.

INTEGRATE is funded by the 3rd EU Health Programme and will run over three years (September 2017-August 2020)

The main objective of INTEGRATE is to integrate early diagnosis and linkage to prevention and care of HIV, viral hepatitis, TB and STIs in EU member states by 2020.

Press Release from the European Commission

Read mroe about the Joint Action INTEGRATE here

For more information follow INTEGRATE on Facebook and Twitter

 
New EU project

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here

Projects and Collaborations